Biolife Solutions (BLFS) Non-Current Deferred Tax Liability (2018 - 2026)
Biolife Solutions' (BLFS) quarterly Non-Current Deferred Tax Liability came in at $198000.0 in Q1 2026, up 52.31% year-on-year from $130000.0 in Q1 2025, and up 4.76% on a QoQ basis from $189000.0 in Q4 2025.
Biolife Solutions (BLFS) Non-Current Deferred Tax Liability (2018 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has 7 years of Non-Current Deferred Tax Liability data on file, last reported at $198000.0 in Q1 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability rose 52.31% year-over-year to $198000.0 in Q1 2026; TTM through Mar 2026 was $198000.0, a 52.31% increase from a year earlier, with the FY2025 full-year figure at $189000.0, down 96.2% from the prior year.
- Non-Current Deferred Tax Liability for Q1 2026 stood at $198000.0, up from $189000.0 in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for BLFS reached as high as $5.0 million in Q4 2024 and fell as low as $100000.0 in Q3 2024.
- Historically, Non-Current Deferred Tax Liability has averaged $820529.4 across 5 years, with a median of $198000.0 in 2026.
- Across the five-year window, Non-Current Deferred Tax Liability surged 4268.42% in 2024 and tumbled 96.2% in 2025, its largest moves.
- Year by year, Non-Current Deferred Tax Liability stood at $250000.0 in 2022, then plunged by 54.4% to $114000.0 in 2023, then jumped by 4268.42% to $5.0 million in 2024, then tumbled by 96.2% to $189000.0 in 2025, then advanced by 4.76% to $198000.0 in 2026.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $198000.0 in Q1 2026, $189000.0 in Q4 2025, and $189000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Biolife Solutions | 1.50 Bn | 1.42 Bn | 17.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 198,000.00 |
| Mar 31, 2026 | 198,000.00 |
| Dec 31, 2025 | 189,000.00 |
| Dec 31, 2025 | 189,000.00 |
| Sep 30, 2025 | 189,000.00 |
| Sep 30, 2025 | 189,000.00 |
| Jun 30, 2025 | 175,000.00 |
| Jun 30, 2025 | 175,000.00 |
| Mar 31, 2025 | 130,000.00 |
| Mar 31, 2025 | 130,000.00 |
| Dec 31, 2024 | 4.98 Mn |
| Dec 31, 2024 | 4.98 Mn |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 193,000.00 |
| Jun 30, 2024 | 193,000.00 |
| Mar 31, 2024 | 193,000.00 |
| Mar 31, 2024 | 193,000.00 |
| Dec 31, 2023 | 114,000.00 |
| Dec 31, 2023 | 114,000.00 |